AURKAP1: A Protein Exploring for Drug Targets and Biomarkers (G6791)

Target Name: AURKAP1

NCBI ID: G6791

AURKAP1

Other Name(s): AURKAPS1 | Aurora kinase A pseudogene 1 | AurAps1 | aurora kinase A pseudogene 1 | STK6P

AURKAP1: A Protein Exploring for Drug Targets and Biomarkers

AURKAP1 (AURKAPS1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a part of the AP-1 gene family, which is known for its role in cell signaling and development.

One of the things that makes AURKAP1 an interesting potential drug target is its involvement in the development and progression of various diseases, including cancer. The AURKAP1 gene has been shown to be involved in the regulation of cell proliferation, which is a key factor in the development of cancer.

In addition to its involvement in cancer, AURKAP1 has also been linked to a number of other diseases and disorders. For example, it has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's. It has also been linked to the development of diseases of the heart, including heart failure and arrhythmia.

Despite its involvement in a number of diseases, AURKAP1 is still a relatively well-known protein. This is because it is only one of many proteins that have been shown to be involved in the regulation of cell proliferation and other cellular processes. As a result, research into AURKAP1 and its potential as a drug target is still in its early stages.

However, the potential benefits of AURKAP1 as a drug target are significant. If AURKAP1 is found to be involved in the development and progression of certain diseases, it could be potential target for new treatments. For example, if AURKAP1 is shown to be involved in the development of cancer, it could be a potential target for cancer therapies that target this protein.

In addition, AURKAP1 could also be a potential biomarker for some diseases. By measuring the levels of AURKAP1 in tissues or fluids, researchers could potentially use AURKAP1 as a diagnostic tool for diseases such as cancer, neurodegenerative diseases, and heart failure.

Overall, AURKAP1 is an intriguing protein that is being studied for its potential as a drug target and biomarker. While more research is needed to fully understand its role in disease and its potential as a therapeutic target, its potential implications for the treatment of a wide range of diseases make it a promising area of research.

Protein Name: Aurora Kinase A Pseudogene 1

The "AURKAP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AURKAP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets